Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1202 (LINC01202) is a member of the long non-coding RNA family, specifically a long intergenic non-protein coding RNA (lincRNA), which means it is a transcript longer than 200 nucleotides that does not encode a protein and is located between protein-coding genes on the genome[1][3]. LincRNAs are known to participate in diverse regulatory roles, including chromatin modulation, recruitment of transcriptional regulators, and possibly scaffolding for nuclear structures, although for most individual lincRNAs—including LINC01202—precise biological and disease roles remain poorly characterized[3][7]. Some lincRNAs have been implicated in the regulation of oncogenes or tumor suppressor genes and may show tissue specificity or differential expression in cancer versus normal tissues; however, there is insufficient direct data on LINC01202 regarding its function, disease association, or therapeutic targeting[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1202 (LINC01202).